Search Results - "Pétas, A"

Refine Results
  1. 1

    Viscoelastic memory and self-expansion of self-reinforced bioabsorbable stents by Välimaa, T, Laaksovirta, S, Tammela, T.L.J, Laippala, P, Talja, M, Isotalo, T, Pétas, A, Taari, K, Törmälä, P

    Published in Biomaterials (01-09-2002)
    “…The possibility to decide the speed and rate of expansion of stents is of great clinical importance by reason of the varying requirements for different…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Bacterial adherence to self-reinforced polyglycolic acid and self-reinforced polylactic acid 96 urological spiral stents in vitro by Pétas, Anssi, Vuopio-Varkila, Jaana, Siitonen, Anja, Välimaa, Tero, Talja, Martti, Taari, Kimmo

    Published in Biomaterials (01-04-1998)
    “…Synopsis The aim of this study was to evaluate the bacterial adherence to biodegradable self-reinforced polyglycolic acid (SR-PGA) and self-reinforced…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The biodegradable self‐reinforced poly‐dl‐lactic acid spiral stent compared with a suprapubic catheter in the treatment of post‐operative urinary retention after visual laser ablation of the prostate by PÉTAS, A., TALJA, M., TAMMELA, T.L.J., TAARI, K., VÄLIMAA, T., TÖRMÄLÄ, P.

    Published in British Journal of Urology (01-09-1997)
    “…Objective  To evaluate the efficacy and safety of a biodegradable self‐reinforced poly‐dl‐lactic acid (SR‐PLA) spiral stent compared with a suprapubic catheter…”
    Get full text
    Journal Article
  7. 7

    Effects of biodegradable self‐reinforced polyglycolic acid, poly‐dl‐lactic acid and stainless‐steel spiral stents on uroepithelium after Nd:YAG laser irradiation of the canine prostate by PÉTAS, A., KÄRKKÄINEN, P., TALJA, M., TAARI, K., LAATO, M., VÄLIMAA, T., TÖRMÄLÄ, P.

    Published in British Journal of Urology (01-12-1997)
    “…Objective  To evaluate the safety and tissue effects on canine uroepithelium and prostate of biodegradable self‐reinforced polyglycolic acid (SR‐PGA) and…”
    Get full text
    Journal Article
  8. 8

    A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate by Pétas, A, Talja, M, Tammela, T, Taari, K, Lehtoranta, K, Välimaa, T, Törmälä, P

    Published in The Journal of urology (01-01-1997)
    “…A randomized controlled study was done to evaluate the efficacy of the self-reinforced polyglycolic acid spiral stent compared to a suprapubic catheter, and…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    The role of hydrogen electrolysers in frequency related ancillary services: A case study in the Iberian Peninsula up to 2040 by Ribeiro, Fernando J., Lopes, João A. Peças, Fernandes, Francisco S., Soares, Filipe J., Madureira, André G.

    Published in Sustainable Energy, Grids and Networks (01-09-2023)
    “…This paper investigates the contribution of hydrogen electrolysers (HEs) for frequency related Ancillary Services (AS), namely Frequency Containment Reserve…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy by Rannikko, Antti, Pétas, Anssi, Taari, Kimmo

    Published in Urology (Ridgewood, N.J.) (01-11-2004)
    “…To determine whether short-term treatment of patients about to undergo transurethral resection of the prostate (TURP) with tranexamic acid (TXA) would be…”
    Get full text
    Journal Article
  17. 17

    Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation by Rannikko, Antti, Petas, Anssi, Rannikko, Sakari, Adlercreutz, Herman

    Published in The Prostate (01-01-2006)
    “…BACKGROUND Phytoestrogens have been suggested to reduce the risk of prostate cancer (CaP), but no data exists on how oral phytoestrogen supplementation…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Duration of testosterone suppression after a 9.45 mg implant of the GnRH-analogue buserelin in patients with localised carcinoma of the prostate a 12-month follow-up study by PETTERSSON, Bill, VARENHORST, Eberhard, PETAS, Anssi, SANDOW, Jürgen

    Published in European urology (01-09-2006)
    “…(1) To determine the duration of androgen deprivation after a single buserelin implant 9.45 mg in the neoadjuvant setting in combination with curative…”
    Get full text
    Journal Article